These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7221889)

  • 1. A prognostic model for clinical stage I melanoma of the lower extremity. Location on foot as independent risk factor for recurrent disease.
    Day CL; Sober AJ; Kopf AW; Lew RA; Mihm MC; Golomb FM; Hennessey P; Harris MN; Gumport SL; Raker JW; Malt RA; Cosimi AB; Wood WC; Roses DF; Gorstein F; Fitzpatrick TB; Postel A
    Surgery; 1981 May; 89(5):599-603. PubMed ID: 7221889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thick cutaneous malignant melanoma: a reappraisal of prognostic factors.
    Massi D; Borgognoni L; Franchi A; Martini L; Reali UM; Santucci M
    Melanoma Res; 2000 Apr; 10(2):153-64. PubMed ID: 10803716
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural history of melanoma in 773 patients with tumor-negative sentinel lymph nodes.
    Zogakis TG; Essner R; Wang HJ; Foshag LJ; Morton DL
    Ann Surg Oncol; 2007 May; 14(5):1604-11. PubMed ID: 17333418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival of patients with melanoma of the lower extremity decreases with distance from the trunk.
    Hsueh EC; Lucci A; Qi K; Morton DL
    Cancer; 1999 Jan; 85(2):383-8. PubMed ID: 10023706
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of anatomical location on prognosis in patients with clinical stage I melanoma.
    Rogers GS; Kopf AW; Rigel DS; Friedman RJ; Levine JL; Levenstein M; Bart RS; Mintzis MM
    Arch Dermatol; 1983 Aug; 119(8):644-9. PubMed ID: 6870318
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early death from clinical stage I melanoma.
    Sober AJ; Day CL; Fitzpatrick TB; Lew RA; Kopf AW; Mihm MC
    J Invest Dermatol; 1983 Jun; 80 Suppl():50s-52s. PubMed ID: 6854054
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node micrometastasis and other histologic factors that predict outcome in patients with thicker melanomas.
    Cherpelis BS; Haddad F; Messina J; Cantor AB; Fitzmorris K; Reintgen DS; Fenske NA; Glass LF
    J Am Acad Dermatol; 2001 May; 44(5):762-6. PubMed ID: 11312421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age and gender are significant independent predictors of survival in primary cutaneous melanoma.
    Lasithiotakis K; Leiter U; Meier F; Eigentler T; Metzler G; Moehrle M; Breuninger H; Garbe C
    Cancer; 2008 Apr; 112(8):1795-804. PubMed ID: 18306371
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic groups of patients with stage I melanoma.
    Kuehnl-Petzoldt C; Wiebelt H; Berger H
    Arch Dermatol; 1983 Oct; 119(10):816-9. PubMed ID: 6614950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Classification of localized melanoma by the exponential survival trees method.
    Huang X; Soong S; McCarthy WH; Urist MM; Balch CM
    Cancer; 1997 Mar; 79(6):1122-8. PubMed ID: 9070489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
    Rossi CR; Mocellin S; Pasquali S; Pilati P; Nitti D
    Ann Surg Oncol; 2008 Jan; 15(1):310-5. PubMed ID: 17987346
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor mitotic rate is a more powerful prognostic indicator than ulceration in patients with primary cutaneous melanoma: an analysis of 3661 patients from a single center.
    Azzola MF; Shaw HM; Thompson JF; Soong SJ; Scolyer RA; Watson GF; Colman MH; Zhang Y
    Cancer; 2003 Mar; 97(6):1488-98. PubMed ID: 12627514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic and prognostic significance of dermal Ki67 expression, mitoses, and tumorigenicity in thin invasive cutaneous melanoma.
    Gimotty PA; Van Belle P; Elder DE; Murry T; Montone KT; Xu X; Hotz S; Raines S; Ming ME; Wahl P; Guerry D
    J Clin Oncol; 2005 Nov; 23(31):8048-56. PubMed ID: 16258103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A prognostic model for clinical stage I melanoma of the trunk. Location near the midline is not an independent risk factor for recurrent disease.
    Day CL; Sober AJ; Kopf AW; Lew RA; Mihm MC; Golomb FM; Postel A; Hennessey P; Harris MN; Gumport SL; Raker JW; Malt RA; Cosimi AB; Wood WC; Roses DF; Gorstein F; Fitzpatrick TB
    Am J Surg; 1981 Aug; 142(2):247-51. PubMed ID: 7258536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A retrospective observational study of primary cutaneous malignant melanoma patients treated with excision only compared with excision biopsy followed by wider local excision.
    McKenna DB; Lee RJ; Prescott RJ; Doherty VR
    Br J Dermatol; 2004 Mar; 150(3):523-30. PubMed ID: 15030337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of misdiagnosis and delay in diagnosis on clinical outcome in melanomas of the foot.
    Bennett DR; Wasson D; MacArthur JD; McMillen MA
    J Am Coll Surg; 1994 Sep; 179(3):279-84. PubMed ID: 8069422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Highly sensitive multivariable assay detection of melanocytic differentiation antigens and angiogenesis biomarkers in sentinel lymph nodes with melanoma micrometastases.
    Vitoux D; Mourah S; Kerob D; Verola O; Basset-Seguin N; Baccard M; Schartz N; Ollivaud L; Archimbaud A; Servant JM; Revol M; Toubert ME; Podgorniak MP; Plassa F; Porcher R; Lebbé C
    Arch Dermatol; 2009 Oct; 145(10):1105-13. PubMed ID: 19841396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic variables and prognostic groups for malignant melanoma. The information from Cox and Classification And Regression Trees analysis: an Italian population-based study.
    Crocetti E; Mangone L; Lo Scocco G; Carli P
    Melanoma Res; 2006 Oct; 16(5):429-33. PubMed ID: 17013092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.